Clinical variability in carriers of C1R gene variants: differential diagnosis of Ehlers-­Danlos syndrome types

Ehlers-Danlos syndrome is a group of hereditary connective tissue disorders with pronounced clinical heterogeneity. Of particular interest is an extremely rare periodontal type caused by C1R and C1S gene variants and characterized primarily by dental disorders, skin manifestations, and joint hypermobility.

This paper describes two families. In family F., the proband, a 35-yearold man, and his 6-year-old son were examined. The child had multiple spontaneous hematomas and ecchymoses. The father had pretibial plaques, joint hypermobility, early loss of permanent teeth, and gingival recession. Whole exome sequencing revealed a previously undescribed 

heterozygous variant NM_001733:c.1073G>A (p.Cys358Tyr) in the C1R gene.

In family L., the proband, a 44-year-old woman, presented with chronic arthralgia, joint hypermobility and instability, and frequent infectious diseases. Her 20-year-old son has similar symptoms. Sequencing results also identified a previously undescribed heterozygous variant NM_001733:c.2066A>G (p.Lys689Arg) in the C1R gene.

These observations highlight the need for early genetic testing when Ehlers-Danlos syndrome is suspected and demonstrate the importance of integrating clinical and molecular data for the accurate diagnosis of rare forms of the disease.

1. Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers-­Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175:8-26. doi:10.1002/ajmg.c.31552.

2. Kapferer-­Seebacher I, Pepin M, Werner R, et al. Periodontal Ehlers-­Danlos syndrome is caused by mutations in C1R and C1S, which encode subcomponents C1r and C1s of complement. Am J Hum Genet. 2016;99:1005-14. doi:10.1016/j.ajhg.2016.08.019.

3. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-24. doi:10.1038/gim.2015.30.

4. Ryzhkova OP, Kardymon OL, Prohorchuk EB, et al. Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2). Medical genetics. 2019;18:(2):3-24. (In Russ.) doi:10.25557/2073-7998.2019.02.3-23.

5. Schubach M, Maass T, Nazaretyan L, et al. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-­level scores to improve genome-wide variant predictions. Nucleic Acids Res. 2024;52:D1143-54. doi:10.1093/nar/gkad989.

6. Joseph AW, Joseph SS, Francomano CA, et al. Characteristics, diagnosis, and management of Ehlers-­Danlos syndromes: A review. JAMA Facial Plast Surg. 2018;20:70-5. doi:10.1001/jamafacial.2017.0793.

7. Nikolaeva EA, Semyachkina AN. Geno-phenotypic characteristics of Ehlers-­Danlos syndrome: difficulties of disease type identification and approaches to patogenetic treatment. Ros­siyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Pe­rinatology and Pediatrics). 2021;66:(1):22-30. (In Russ.) doi:10.21508/1027-4065-2021-66-1-22-30.

8. Angwin C, Zschocke J, Kammin T, et al. Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-­Danlos syndrome. Front Genet. 2023; 14:1136339. doi:10.3389/fgene.2023.1136339.

9. S. van DF, Ghali N, Chandratheva A. Ehlers-­Danlos syndromes: importance of defining the type. Pract Neurol. 2024;24:90-7. doi:10.1136/pn-2023-003703.

10. Gröbner R, Kapferer-­Seebacher I, Amberger A, et al. C1R mutations trigger constitutive complement 1 activation in periodontal Ehlers-­Danlos Syndrome. Front Immunol. 2019; 10:2537. doi:10.3389/fimmu.2019.02537.

11. Lepperdinger U, Angwin C, Milnes D, et al. Oral characteristics in adult individuals with periodontal Ehlers-­Danlos syndrome. J Clin Periodontol. 2022;49:1244-52. doi:10.1111/jcpe.13698.